Breaking News Instant updates and real-time market news.

CSRA

CSRA

$32.60

1.04 (3.30%)

, KSS

Kohl's

$41.90

1.51 (3.74%)

09:55
09/06/17
09/06
09:55
09/06/17
09:55

Early notable gainers among liquid option names on September 6th

Notable gainers among liquid option names this morning include CSRA (CSRA) $32.83 +1.28, Kohl's (KSS) $41.97 +1.57, Gap (GPS) $24.93 +0.91, CSX (CSX) $50.72 +1.73, and Macy's (M) $21.72 +0.72.

CSRA

CSRA

$32.60

1.04 (3.30%)

KSS

Kohl's

$41.90

1.51 (3.74%)

GPS

Gap

$24.72

0.69 (2.87%)

CSX

CSX

$48.99

-0.79 (-1.59%)

M

Macy's

$21.78

0.7676 (3.65%)

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 29

    Oct

  • 30

    Oct

  • 09

    Nov

CSRA CSRA
$32.60

1.04 (3.30%)

04/05/17
04/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Burlington Stores (BURL) initiated with an Outperform at William Blair. 2. Booz Allen (BAH) was initiated with an In Line while CSRA (CSRA) was initiated with an Outperform at Evercore ISI. 3. Guidance Software (GUID) initiated with an Overweight at Piper Jaffray. 4. Acacia Communications (ACIA) initiated with a Neutral at B. Riley. 5. Keysight Technologies (KEYS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/17
EVER
04/04/17
INITIATION
Target $34
EVER
Outperform
CSRA initiated with an Outperform at Evercore ISI
Evercore ISI analyst Rayna Kumar initiated CSRA with an Overweight and a $34 price target citing industry leading EBITDA margins driven by exposure to high margin, fixed price contracts, a next generation IT focus, and financial discipline.
07/11/17
RBCM
07/11/17
NO CHANGE
RBCM
Defense stocks still poised for beat and raise results, says RBC Capital
RBC Capital analyst Matthew McConnell says that defense stocks remain poised for beat and raise results for an extended period, given geopolitical tensions in many parts of the world. He believes that the companies most likely to raise their 2017 in conjunction with their Q2 results are General Dynamics (GD), L3 Technologies (LLL), Raytheon (RTN), and Northrop Grumman (NOC). He recommends Raytheon, General Dynamics, Northrop Grumman, CSRA (CSRA), and KEYW (KEYW).
03/16/17
VERT
03/16/17
INITIATION
VERT
Hold
CSRA initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha started CSRA with a Hold rating.
KSS Kohl's
$41.90

1.51 (3.74%)

08/10/17
JEFF
08/10/17
NO CHANGE
JEFF
Kohl's shares defended at Jefferies
08/10/17
GDHS
08/10/17
UPGRADE
GDHS
Hold
Kohl's upgraded to Hold from Reduce at Gordon Haskett
Gordon Haskett upgraded Kohl's to Hold saying earnings downside looks limited post today's results. The firm raised its price target for the shares to $37 from $36.
08/10/17
FBCO
08/10/17
UPGRADE
FBCO
Neutral
Kohl's upgraded to Neutral from Underperform at Credit Suisse
08/11/17
08/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Overweight from Equal Weight at Stephens with analyst Ben Bienvenu saying that the company's multi-year investments have led to a better in-store experience, which he sees continuing to drive momentum. 2. Kohl's (KSS) upgraded to Neutral from Underperform at Credit Suisse. 3. Huntington Bancshares (HBAN) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying the "disappointing" expense guidance has lowered expectations while Huntington should grow earnings faster than any regional bank peer in fiscal 2018 and fiscal 2019. 4. Axalta Coating (AXTA) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the 16% pullback over the past three weeks has created an investment opportunity. 5. Perrigo (PRGO) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the quarterly results may mark the beginning of inflection towards stabilization in the Rx business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPS Gap
$24.72

0.69 (2.87%)

08/18/17
JEFF
08/18/17
NO CHANGE
Target $35
JEFF
Buy
Gap posted solid quarter in tough environment, says Jefferies
Jefferies analyst Randal Konik views Gap's Q2 results as solid amid a tough operating environment for retailers. The company's beat was high quality, with upside on comps and gross margin, Konik tells investors in a post-earnings research note. He notes Q2 was the third consecutive quarter of positive comps. The analyst reiterates a Buy rating on Gap with a $35 price target.
08/18/17
UBSW
08/18/17
NO CHANGE
Target $23
UBSW
Sell
Gap beat expectations but downside risk remains, says UBS
UBS analyst Michael Binetti said Gap had solid Q2 results but he does not see signs of a sustainable earnings acceleration. The analyst sees downside risk from gross margins and SG&A pressure in the second half of the year but raised his estimates slightly due to the Q2 beat. Binetti reiterated his Sell rating and $23 price target on Gap shares.
09/01/17
SBSH
09/01/17
UPGRADE
Target $24
SBSH
Neutral
Gap upgraded to Neutral from Sell at Citi
Citi analyst Paul Lejuez upgraded Gap to Neutral citing low expectations and support from the 4% dividend yield. Concerns of a slowdown at Old Navy appear more priced in at current valuation levels, Lejuez tells investors in a research note. He raised his price target for the shares to $24 from $22. Gap closed yesterday up 14c to $23.62.
09/01/17
09/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Palo Alto Networks (PANW) was upgraded to Overweight from Neutral at JPMorgan and to Overweight from Equal-Weight at First Analysis. 2. Gap (GPS) upgraded to Neutral from Sell at Citi, with analyst Paul Lejuez saying concerns of a slowdown at Old Navy appear more priced in at current valuation levels. He raised his price target for the shares to $24 from $22. 3. Gerdau (GGB) upgraded to Overweight from Neutral at JPMorgan with analyst Rodolfo Angele saying the company's business environment has improved. 4. Owens & Minor (OMI) upgraded to Neutral from Underperform at Baird with analyst Eric Coldwell citing its relative underperformance. 5. Toronto-Dominion (TD) upgraded to Outperform from Sector Perform at National Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CSX CSX
$48.99

-0.79 (-1.59%)

08/01/17
COWN
08/01/17
NO CHANGE
Target $130
COWN
Outperform
Norfolk Southern poised to take market share from CSX, says Cowen
Cowen analyst Jason Seidl said 80% of respondents in his survey of CSX (CSX) users said they've experienced service issues since the company began Precision Railroading and nearly 40% have switched some freight to Norfolk Southern (NSC) and 67% have switched freight to a trucker. He believes Norfolk Southern will show additional market share gains in Q3 and increase its earnings over that time. Seidl has an Outperform rating and $130 price target on Norfolk Southern shares.
09/05/17
OPCO
09/05/17
NO CHANGE
OPCO
Oppenheimer discontinuing research coverage of CSX Corporation
Oppenheimer is discontinuing research coverage of CSX Corporation, previously rated Perform. The decision is unrelated to any awareness on its part of any material change in the fundamental condition of the company.
08/23/17
AGIS
08/23/17
NO CHANGE
Target $64
AGIS
Buy
CSX operating issues appear to be moderating, says Aegis
Aegis analyst Jeffrey Kauffman said CSX CEO Hunter Harrison has been making changes at an "aggressive pace" and he notes that the Wall Street Journal and other industry periodicals note a growing customer outcry about on-time delivery declines, which the company's reported operating metrics seem to confirm. However, he said the situation appears to be leveling out and he has seen improvement in some key metrics over the last 2 weeks. The analyst, who sees some near-term EPS risk from operating changes but believes the changes will lead to stronger long-term EPS growth, suggests buying amid the weakness and keeps his Buy rating and $64 price target on CSX shares.
08/29/17
BMOC
08/29/17
NO CHANGE
BMOC
Railroad stock pullback has improved outlook, says BMO Capital
BMO Capital analyst Fadi Chamoun says that the decline of the valuation of railroad stocks in the wake of their Q2 results has made the sector more attractive. The analyst says that the outlook of products comprising 71% of railroad volumes is positive, and Chamoun remains upbeat on the sector's fundamentals. Chamoun keeps Outperform ratings on CSX (CSX), Union Pacific (UNP), Canadian Pacific (CP), and China Metro-Rural (CNR).
M Macy's
$21.78

0.7676 (3.65%)

09/06/17
COWN
09/06/17
NO CHANGE
Target $23
COWN
Market Perform
Macy's in early innings of leadership transformation, says Cowen
Cowen analyst Oliver Chen believes Macy's is in the early innings of a leadership transformation which he believes should drive increased speed, digital innovation/integration, and accelerated product differentiation. He also sees less negative comps in the second half of 2017 on a continuation of product initiatives and new marketing initiatives. Chen maintained his Market Perform rating and $23 price target on Macy''s shares.
08/11/17
UBSW
08/11/17
NO CHANGE
Target $21
UBSW
Neutral
Macy's Q2 better than feared, guidance hurts confidence, says UBS
UBS analyst Michael Binetti said Macy's reported Q2 results that were better than feared, but its second half guidance has damaged the confidence that its positive trends are sustainable. The analyst lowered his estimates and his price target to $21 from $23. Binetti maintained his Neutral rating on Macy's shares.
06/21/17
GDHS
06/21/17
NO CHANGE
GDHS
Nike-Amazon pact yet another department store headwind, says Gordon Haskett
Gordon Haskett analyst noted the reports of Nike (NKE) nearing a deal to sell directly on Amazon (AMZN), which he said wouldn't impact trends overnight but would represent another headwind for department stores, particularly J.C. Penney (JCP) and Kohl's (KSS), where the brand has a larger penetration than at Macy's (M) and Nordstrom (JWN). He keeps an Accumulate rating on Nordstrom, a Hold rating on Macy's and Reduce rating on both J.C. Penney and Kohl's.
06/07/17
GSCO
06/07/17
NO CHANGE
Target $25
GSCO
Neutral
Macy's price target lowered to $25 from $28 at Goldman Sachs
Goldman analyst Lindsay Drucker Mann lowerd Macy's price target to $25 from $28 to reflect weaker margin trends and operating earnings following the company's Investor Day. The analyst is encouraged by the detail around strategic initiatives and has confidence in -3-4% FY17 comp guidance range. Shares are Neutral rated.

TODAY'S FREE FLY STORIES

DE

Deere

$139.23

2.31 (1.69%)

20:25
11/21/17
11/21
20:25
11/21/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 28

    Nov

PCRX

Pacira

$42.65

0.45 (1.07%)

19:24
11/21/17
11/21
19:24
11/21/17
19:24
Recommendations
Pacira analyst commentary at BMO Capital »

October Symphony data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 14

    Dec

  • 06

    Apr

CEIX

CONSOL Energy

, ICON

Iconix Brand

$2.55

0.28 (12.33%)

19:00
11/21/17
11/21
19:00
11/21/17
19:00
Hot Stocks
S&P announces changes to S&P SmallCap 600 index »

S&P Dow Jones Indices…

CEIX

CONSOL Energy

ICON

Iconix Brand

$2.55

0.28 (12.33%)

CNX

Consol

$16.27

0.23 (1.43%)

PDFS

PDF Solutions

$15.86

0.11 (0.70%)

BBOX

Black Box

$4.15

0.55 (15.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIVO

TiVo

$17.65

0.15 (0.86%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

18:52
11/21/17
11/21
18:52
11/21/17
18:52
Recommendations
TiVo, Comcast analyst commentary at JPMorgan »

ITC ruling a…

TIVO

TiVo

$17.65

0.15 (0.86%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$25.35

-2.86 (-10.14%)

18:48
11/21/17
11/21
18:48
11/21/17
18:48
Recommendations
Glaukos analyst commentary at Piper Jaffray »

Glaukos selloff due to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$103.00

0.25 (0.24%)

, CMCSA

Comcast

$36.42

0.59 (1.65%)

18:31
11/21/17
11/21
18:31
11/21/17
18:31
Periodicals
Hulu sued for failure to offer audio service for blind subscribers, NY Post says »

Advocacy groups are suing…

DIS

Disney

$103.00

0.25 (0.24%)

CMCSA

Comcast

$36.42

0.59 (1.65%)

CMCSK

Comcast

TWX

Time Warner

$89.56

1.85 (2.11%)

FOX

21st Century Fox

$30.10

0.2 (0.67%)

FOXA

21st Century Fox

$30.88

0.22 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGA

Magna

$54.29

0.37 (0.69%)

18:23
11/21/17
11/21
18:23
11/21/17
18:23
Hot Stocks
Magna announces two share repurchase programs »

Magna International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 16

    Jan

PTLA

Portola Pharmaceuticals

$50.80

1.29 (2.61%)

18:23
11/21/17
11/21
18:23
11/21/17
18:23
Hot Stocks
Portola: FDA extends review period for PAS for Bevyxxa »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

PBMD

Prima BioMed

$1.65

-0.03 (-1.79%)

18:09
11/21/17
11/21
18:09
11/21/17
18:09
Hot Stocks
Prima BioMed secures European patent grant for lead product IMP321 in cancer »

Prima BioMed announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$36.70

0.39 (1.07%)

18:06
11/21/17
11/21
18:06
11/21/17
18:06
Earnings
Copart reports Q1 non-GAAP EPS 33c, consensus 27c »

Reports Q1 revenue 419.2M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 19

    Dec

PCTY

Paylocity

$47.79

-0.64 (-1.32%)

18:01
11/21/17
11/21
18:01
11/21/17
18:01
Hot Stocks
Paylocity chairman sells 736,845 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MDC

M.D.C. Holdings

$35.10

0.91 (2.66%)

18:01
11/21/17
11/21
18:01
11/21/17
18:01
Hot Stocks
M.D.C. Holdings declares special 8% stock dividend »

M.D.C. Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDFS

PDF Solutions

$15.86

0.11 (0.70%)

, BBOX

Black Box

$4.15

0.55 (15.28%)

17:59
11/21/17
11/21
17:59
11/21/17
17:59
Hot Stocks
Breaking Hot Stocks news story on PDF Solutions, Black Box »

PDF Solutions to replace…

PDFS

PDF Solutions

$15.86

0.11 (0.70%)

BBOX

Black Box

$4.15

0.55 (15.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

17:58
11/21/17
11/21
17:58
11/21/17
17:58
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. sees pressure on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CEIX

CONSOL Energy

, ICON

Iconix Brand

$2.55

0.28 (12.33%)

17:57
11/21/17
11/21
17:57
11/21/17
17:57
Hot Stocks
Breaking Hot Stocks news story on CONSOL Energy, Iconix Brand »

CONSOL Energy to replace…

CEIX

CONSOL Energy

ICON

Iconix Brand

$2.55

0.28 (12.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$22.46

0.34 (1.54%)

17:53
11/21/17
11/21
17:53
11/21/17
17:53
Hot Stocks
Breaking Hot Stocks news story on HP Inc. »

HP Inc. says returned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

TMQ

Trilogy Metals

$0.92

-0.0211 (-2.25%)

17:53
11/21/17
11/21
17:53
11/21/17
17:53
Syndicate
Breaking Syndicate news story on Trilogy Metals »

Trilogy Metals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$37.74

0.74 (2.00%)

17:50
11/21/17
11/21
17:50
11/21/17
17:50
Initiation
Terreno Realty initiated at National Securities »

Terreno Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HPQ

HP Inc.

$22.47

0.355 (1.61%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Hot Stocks
HP Inc.: 'Stay tuned' for news on metal 3D printing »

Says plans to introduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

THC

Tenet

$13.34

0.17 (1.29%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
Tenet initiated at William Blair »

Tenet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPNT

LifePoint

$43.85

0.65 (1.50%)

17:47
11/21/17
11/21
17:47
11/21/17
17:47
Initiation
LifePoint initiated at William Blair »

LifePoint initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$67.98

1.46 (2.19%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
LHC Group initiated at William Blair »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

HLS

HealthSouth

$48.46

0.85 (1.79%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HealthSouth initiated at William Blair »

HealthSouth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCA

HCA Healthcare

$75.89

1.28 (1.72%)

17:46
11/21/17
11/21
17:46
11/21/17
17:46
Initiation
HCA Healthcare initiated at William Blair »

HCA Healthcare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMED

Amedisys

$54.97

2.29 (4.35%)

17:45
11/21/17
11/21
17:45
11/21/17
17:45
Initiation
Amedisys initiated at William Blair »

Amedisys initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.